0001022079-20-000186.txt : 20201023
0001022079-20-000186.hdr.sgml : 20201023
20201023164224
ACCESSION NUMBER: 0001022079-20-000186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201021
FILED AS OF DATE: 20201023
DATE AS OF CHANGE: 20201023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEPPE MICHAEL J
CENTRAL INDEX KEY: 0001771759
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 201258166
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
STREET 2: C/O QUEST DIAGNOSTICS
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_160348572710096.xml
FORM 4
X0306
4
2020-10-21
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001771759
DEPPE MICHAEL J
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
VP, Corp. Controller & CAO
Common Stock
2020-10-21
4
M
0
4750
56.82
A
29785
D
Common Stock
2020-10-21
4
M
0
5700
57.605
A
35485
D
Common Stock
2020-10-21
4
S
0
5700
125
D
29785
D
Common Stock
2020-10-21
4
S
0
4750
125
D
25090
D
401(k)
638
I
401(k)
Non-Qualifed Stock Option (right to buy)
56.82
2020-10-21
4
M
0
4750
56.82
D
2021-02-15
Common Stock
4750.0
0
D
Non-Qualifed Stock Option (right to buy)
57.605
2020-10-21
4
M
0
5700
57.605
D
2022-02-22
Common Stock
5700.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020.
The amount includes approximately 46 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014.
The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015.
William J. O'Shaughnessy, Jr. Attorney in Fact for Michael J. Deppe
2020-10-23